People | July 18, 2022
Avet Pharmaceuticals appoints George Svokos as President &CEO
George Svokos joins Avet after serving as a strategic business advisor to numerous global healthcare companies
George Svokos joins Avet after serving as a strategic business advisor to numerous global healthcare companies
She joins Enveda from Gilead Sciences
Supports development and commercialization of complex oral drugs using sensitive molecules, including biologicals
Novavax’ clinical development program reported no severe allergic reactions
The GMP facility is equipped with state of art machinery for the needs of Global commercial requirements
The expansion at CDMO facility in South Haven, will bring a new 4,000-gallon multi-use reactor train consisting of glass lined and stainless-steel materials of construction
Plant is part of the company's CAD $30 million capital investment in the site
The round was closed with an investment from the European Circular Bioeconomy Fund (ECBF) and the two existing investors, Sofinnova Partners and Novo Seeds
The combined company will be able to better serve both our global and regional customers with local production
Domestic devices are usually preferred over imported medical devices in the national or regional procurement.
Subscribe To Our Newsletter & Stay Updated
